4//SEC Filing
McBarron Paul 4
Accession 0001104659-13-043961
CIK 0001130166other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
6.5 KB
Accession
0001104659-13-043961
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Purchase
Common Stock, $0.001 par value per share
2013-05-21$3.00/sh+8,333$24,999→ 65,481 total - Purchase
Common Stock, $0.001 par value per share
2013-05-21$3.08/sh+4,615$14,214→ 70,096 total
Footnotes (1)
- [F1]The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 30,714 shares are represented by unvested restricted stock units.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357397
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:30 PM ET
- Size
- 6.5 KB